CARTOCCI ALESSANDRA

Contacts

0577233309 [int.3309]

Teaching activities

Completion accademic year: 2024/2025

Course year: 1 MEDICINA D'EMERGENZA-URGENZA A.Y. 2024/2025

Completion accademic year: 2023/2024

Course year: 3 IGIENE E MEDICINA PREVENTIVA A.Y. 2021/2022

Research

Ultime pubblicazioni:

  • Rubegni, G., Ferri, P., Mocciardini, E., Mapelli, L., Savaresi, G., Prandini, R., et al. (2026). Smartphone-Driven Augmented Reality Headset for Low-Light Mobility Assistance in Retinitis Pigmentosa. AMERICAN JOURNAL OF OPHTHALMOLOGY, 281, 440-448 [10.1016/j.ajo.2025.09.048]. - view more
  • Luschi, A., Tognetti, L., Cartocci, A., Cevenini, G., Rubegni, P., Iadanza, E. (2025). Advancing synthetic data for dermatology: GAN comparison with multi-metric and expert validation approach. HEALTH AND TECHNOLOGY [10.1007/s12553-025-00971-x]. - view more
  • Cartocci, A., Marianello, D., Limaj, S., Biuzzi, C., Simeone, F., Nante, N., et al. (2025). A long-standing model-driven approach for optimizing blood resource allocation in cardiac elective surgery. INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT, 1-6 [10.1080/20479700.2024.2445451]. - view more
  • Sicuranza, A., Breccia, M., Iuliano, F., Gugliotta, G., Castagnetti, F., Lunghi, M., et al. (2025). Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies. VACCINES, 13(4) [10.3390/vaccines13040419]. - view more
  • Trovato, E., Bianchelli, T., Odorici, G., Cuccia, A., Di Lernia, V.G., Lasagni, C., et al. (2025). Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies. DERMATOLOGY AND THERAPY, 15(7), 1941-1952 [10.1007/s13555-025-01442-x]. - view more